Mingfang Diao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mingfang Diao has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Jianjun Sun
Department of Otorhinolaryngology Head and Neck Surgery, Peking University International Hospital, Beijing 102206, China
6 shared publications Peili Zhang
Department of Endoscopic Ear Surgery, Senior Department of Otorhinolaryngology Head and Neck Surgery, The Sixth Medical Center of PLA General Hospital of Beijing
4 shared publicationsDong-Lan Chen
3 shared publicationsFangjie Tian
Department of Otolaryngology Head and Neck Surgery Sixth Medical Center of Chinese PLA General Hospital Beijing China
3 shared publicationsJianjun Sun
Department of Otorhinolaryngology Head and Neck Surgery Peking University International Hospital 102206 Beijing China
3 shared publications- Zhimin Zhou
College of Biological and Pharmaceutical Sciences, China Three Gorges University, Yichang 443002, China; Biomedical Barriers Research Center, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, China
3 shared publications
Latest Publications
- Open Access
- 29 April 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1808182
Prognostic factors for pediatric sudden sensorineural hearing loss: a systematic review and meta-analysis
Objective: This systematic review and meta-analysis aimed to identify prognostic factors influencing hearing recovery in children with sudden sensorineural hearing loss (SSNHL), thereby providing a reference for developing prevention strategies and optimizing therapeutic interventions. Methods: We conducted a comprehensive search of PubMed, Web of Science, Cochrane Library, Embase, CNKI, and SinoMed databases to identify relevant studies published prior to 2024. Inclusion criteria encompassed pediatric patients with SSNHL (12 years (OR: 1.911, P = 0.034), treatment delay ≤ 14 days (OR: 6.402, P < 0.001), and an ascending audiogram curve (OR: 6.910, P < 0.001). Conversely, poorer outcomes were associated with profound hearing loss curves (OR: 0.376, P < 0.001) and initial pure-tone average (PTA) thresholds >80 dB HL (OR: 0.451, P = 0.005). Conclusion: Early intervention (≤14 days) and targeted treatment for profound hearing loss (PTA > 80 dB HL) hold promise for improving pediatric outcomes. Systemic inflammatory markers (neutrophil-to-lymphocyte ratio) and age-specific pathophysiological mechanisms warrant further investigation. Conducting multicenter prospective studies is essential to validate these findings and establish standardized diagnostic and treatment protocols for pediatric SSNHL. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD42024612409 , CRD42024612409.
- 29 April 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1808182
Open AccessPrognostic factors for pediatric sudden sensorineural hearing loss: a systematic review and meta-analysis
Objective: This systematic review and meta-analysis aimed to identify prognostic factors influencing hearing recovery in children with sudden sensorineural hearing loss (SSNHL), thereby providing a reference for developing prevention strategies and optimizing therapeutic interventions. Methods: We conducted a comprehensive search of PubMed, Web of Science, Cochrane Library, Embase, CNKI, and SinoMed databases to identify relevant studies published prior to 2024. Inclusion criteria encompassed pediatric patients with SSNHL (12 years (OR: 1.911, P = 0.034), treatment delay ≤ 14 days (OR: 6.402, P < 0.001), and an ascending audiogram curve (OR: 6.910, P < 0.001). Conversely, poorer outcomes were associated with profound hearing loss curves (OR: 0.376, P < 0.001) and initial pure-tone average (PTA) thresholds >80 dB HL (OR: 0.451, P = 0.005). Conclusion: Early intervention (≤14 days) and targeted treatment for profound hearing loss (PTA > 80 dB HL) hold promise for improving pediatric outcomes. Systemic inflammatory markers (neutrophil-to-lymphocyte ratio) and age-specific pathophysiological mechanisms warrant further investigation. Conducting multicenter prospective studies is essential to validate these findings and establish standardized diagnostic and treatment protocols for pediatric SSNHL. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD42024612409 , CRD42024612409.
- Open Access
- 10 April 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1796414
The prognostic value of semicircular canal function testing in idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis
Purpose: This study aims to examine the prognostic value of the video head impulse test (vHIT) and caloric test in predicting hearing recovery with Idiopathic Sudden Sensorineural Hearing Loss (ISSHL). Methods: A comprehensive literature search was conducted across PubMed, Web of Science, Embase, China National Knowledge Infrastructure (CNKI), and Wanfang Data Knowledge Service Platform, covering studies published up to September 15, 2025. This meta-analysis included studies examining the association between vestibular function test parameters and hearing recovery outcomes. Data were extracted from eligible Chinese and English publications for a systematic review and meta-analysis of observational studies. This study protocol was registered with PROSPERO. Results: This meta-analysis included 781 patients from 7 studies. Normal function of the horizontal semicircular canal in vHIT (OR = 3.14, 95% CI: 1.71–5.77, P < 0.001, I 2 = 0.00%), normal function of the posterior semicircular canal in vHIT (OR = 6.929, 95% CI: 3.242–14.808, P < 0.001, I 2 = 0.00%), and normal caloric test results (OR = 3.184, 95% CI: 1.818–5.575, P < 0.001, I 2 = 0.00%) indicated a favorable prognosis for ISSHL patients. In contrast, normal function of the anterior semicircular canal in vHIT was not associated with prognosis in ISSHL patients ( P = 0.186). Conclusion: vHIT, caloric tests, and Vestibular Evoked Myogenic Potentials (VEMP) can comprehensively evaluate vestibular function in patients with ISSHL. Normal vestibular function is a key factor for favorable hearing prognosis in these patients. Vestibular function testing should be performed as a routine examination in patients with ISSHL, as it provides a more comprehensive understanding of their hearing prognosis. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251156585 , Identifier: CRD420251156585.
- 10 April 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1796414
Open AccessThe prognostic value of semicircular canal function testing in idiopathic sudden sensorineural hearing loss: a systematic review and meta-analysis
Purpose: This study aims to examine the prognostic value of the video head impulse test (vHIT) and caloric test in predicting hearing recovery with Idiopathic Sudden Sensorineural Hearing Loss (ISSHL). Methods: A comprehensive literature search was conducted across PubMed, Web of Science, Embase, China National Knowledge Infrastructure (CNKI), and Wanfang Data Knowledge Service Platform, covering studies published up to September 15, 2025. This meta-analysis included studies examining the association between vestibular function test parameters and hearing recovery outcomes. Data were extracted from eligible Chinese and English publications for a systematic review and meta-analysis of observational studies. This study protocol was registered with PROSPERO. Results: This meta-analysis included 781 patients from 7 studies. Normal function of the horizontal semicircular canal in vHIT (OR = 3.14, 95% CI: 1.71–5.77, P < 0.001, I 2 = 0.00%), normal function of the posterior semicircular canal in vHIT (OR = 6.929, 95% CI: 3.242–14.808, P < 0.001, I 2 = 0.00%), and normal caloric test results (OR = 3.184, 95% CI: 1.818–5.575, P < 0.001, I 2 = 0.00%) indicated a favorable prognosis for ISSHL patients. In contrast, normal function of the anterior semicircular canal in vHIT was not associated with prognosis in ISSHL patients ( P = 0.186). Conclusion: vHIT, caloric tests, and Vestibular Evoked Myogenic Potentials (VEMP) can comprehensively evaluate vestibular function in patients with ISSHL. Normal vestibular function is a key factor for favorable hearing prognosis in these patients. Vestibular function testing should be performed as a routine examination in patients with ISSHL, as it provides a more comprehensive understanding of their hearing prognosis. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251156585 , Identifier: CRD420251156585.
- Open Access
- 1 July 2025
- Published by Tsinghua University Press in Journal of Otology
- Vol. 20 (3) , 190-197
Intratympanic dexamethasone microcrystal-loaded porous PLGA microspheres containing lipoic acid for combined delivery to the inner ear
Objective To develop a sustained-release codelivery system for intratympanic administration of dexamethasone (DEX) and lipoic acid (LA). Methods DEX microcrystals (MCs) were prepared via precipitation, while LA-loaded porous PLGA microspheres (LPMPs) were fabricated using a double emulsion–solvent evaporation method. DEX MCs were physically perfused into LPMPs via negative pressure to form a combined system (DEX MCs+LPMPs). Physicochemical properties, in vitro drug release, pharmacokinetics, and biocompatibility were evaluated. Guinea pigs were used for intratympanic injections of DEX MCs, LPMPs, or DEX MCs+LPMPs. Results The DEX MCs+LPMPs system enabled simultaneous release of both drugs, with DEX exhibiting superior pharmacokinetics (sustained perilymph concentrations up to 7 days) compared to DEX MCs alone. LA release from LPMPs demonstrated prolonged kinetics without burst release. SEM confirmed DEX MCs were localized within/on LPMPs and adhered to the round window membrane (RWM). Histological analysis revealed normal cochlear morphology and no inflammatory response, confirming biocompatibility. Conclusions This novel codelivery system combining microcrystals and porous microspheres achieves sustained dual-drug release, enhances therapeutic efficacy, and offers a promising strategy for managing hearing loss via intratympanic administration.
- 1 July 2025
- Published by Tsinghua University Press in Journal of Otology
- Vol. 20 (3) , 190-197
Open AccessIntratympanic dexamethasone microcrystal-loaded porous PLGA microspheres containing lipoic acid for combined delivery to the inner ear
Objective To develop a sustained-release codelivery system for intratympanic administration of dexamethasone (DEX) and lipoic acid (LA). Methods DEX microcrystals (MCs) were prepared via precipitation, while LA-loaded porous PLGA microspheres (LPMPs) were fabricated using a double emulsion–solvent evaporation method. DEX MCs were physically perfused into LPMPs via negative pressure to form a combined system (DEX MCs+LPMPs). Physicochemical properties, in vitro drug release, pharmacokinetics, and biocompatibility were evaluated. Guinea pigs were used for intratympanic injections of DEX MCs, LPMPs, or DEX MCs+LPMPs. Results The DEX MCs+LPMPs system enabled simultaneous release of both drugs, with DEX exhibiting superior pharmacokinetics (sustained perilymph concentrations up to 7 days) compared to DEX MCs alone. LA release from LPMPs demonstrated prolonged kinetics without burst release. SEM confirmed DEX MCs were localized within/on LPMPs and adhered to the round window membrane (RWM). Histological analysis revealed normal cochlear morphology and no inflammatory response, confirming biocompatibility. Conclusions This novel codelivery system combining microcrystals and porous microspheres achieves sustained dual-drug release, enhances therapeutic efficacy, and offers a promising strategy for managing hearing loss via intratympanic administration.
- 16 March 2024
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 237, 113855
A silk-based hydrogel containing dexamethasone and lipoic acid microcrystals for local delivery to the inner ear
- 16 March 2024
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 237, 113855
A silk-based hydrogel containing dexamethasone and lipoic acid microcrystals for local delivery to the inner ear
- 1 February 2023
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 223, 113191
Intratympanic microcrystals of dexamethasone and lipoic acid for the treatment of cisplatin-induced inner ear injury
- 1 February 2023
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 223, 113191
Intratympanic microcrystals of dexamethasone and lipoic acid for the treatment of cisplatin-induced inner ear injury
- 19 December 2020
- Published by Wiley in Clinical Otolaryngology
- Vol. 46 (3) , 630-634
Analysis of the effects and predictors of tailor‐made notched music therapy for chronic idiopathic tinnitus patients: Our experience with 70 patients
Click on the article title to read more.
- 19 December 2020
- Published by Wiley in Clinical Otolaryngology
- Vol. 46 (3) , 630-634
Analysis of the effects and predictors of tailor‐made notched music therapy for chronic idiopathic tinnitus patients: Our experience with 70 patients
Click on the article title to read more.
- Retracted
- 17 September 2018
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 276 (1) , 281
RETRACTED ARTICLE: Cochlear implant device activation after 7 days in cochlear implant recipients
- 17 September 2018
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 276 (1) , 281
RetractedRETRACTED ARTICLE: Cochlear implant device activation after 7 days in cochlear implant recipients
- 1 June 2015
- Vol. 50 (6) , 518-21
[Hearing rehabilitation of patients with profound unilateral hearing loss].
- 1 June 2015
- Vol. 50 (6) , 518-21
[Hearing rehabilitation of patients with profound unilateral hearing loss].
- 12 November 2013
- Vol. 93 (42) , 3384-7
[Effect of postaurical subcutaneously injection of triamcinolone acetonide for subjective tinnitus].
To determine whether postaurical subcutaneous injection of triamcinolone acetonide is effective for subjective tinnitus refractory to medical treatment. A total of 100 adult patients with subjective tinnitus of cochlear origin were randomly assigned to receive postaurical subcutaneous.Injection of either triamcinolone acetonide (n = 50) or saline solution (n = 50). The treatment protocol comprised 5 injections, one per week for 5 weeks.Improvement was measured by tinnitus severity evaluation index evaluation scale, at baseline and one week after the last injection. The follow-up period was 6 months. No significant difference existed between two groups regarding age, gender, pure tone average, pretreatment tinnitus intensity, tinnitus duration or hearing loss level tinnitus duration (P = 0.316,0.685,0.839,0.682 and 0.881 respectively).No significant post-treatment changes in the tinnitus severity index (experimental group = 52%, control group = 44%) were observed in either group (P = 0.724). The most frequently encountered side effect was pain during injection. The postaurical subcutaneous injection of triamcinolone acetonide has no obvious benefit compared with placebo for subjective tinnitus of cochlear origin refractory to medical treatment.
- 12 November 2013
- Vol. 93 (42) , 3384-7
[Effect of postaurical subcutaneously injection of triamcinolone acetonide for subjective tinnitus].
To determine whether postaurical subcutaneous injection of triamcinolone acetonide is effective for subjective tinnitus refractory to medical treatment. A total of 100 adult patients with subjective tinnitus of cochlear origin were randomly assigned to receive postaurical subcutaneous.Injection of either triamcinolone acetonide (n = 50) or saline solution (n = 50). The treatment protocol comprised 5 injections, one per week for 5 weeks.Improvement was measured by tinnitus severity evaluation index evaluation scale, at baseline and one week after the last injection. The follow-up period was 6 months. No significant difference existed between two groups regarding age, gender, pure tone average, pretreatment tinnitus intensity, tinnitus duration or hearing loss level tinnitus duration (P = 0.316,0.685,0.839,0.682 and 0.881 respectively).No significant post-treatment changes in the tinnitus severity index (experimental group = 52%, control group = 44%) were observed in either group (P = 0.724). The most frequently encountered side effect was pain during injection. The postaurical subcutaneous injection of triamcinolone acetonide has no obvious benefit compared with placebo for subjective tinnitus of cochlear origin refractory to medical treatment.
- 1 November 2013
- Vol. 27 (22) , 1247-51
[Analysis on outer hair cells hazards from occupational exposure to low frequency electric and magnetic fields and magnetic fields and its related factors].
To explore the function of outer hair cells and its influencing factors in the workers of occupational exposure to low frequency electric and magnetic fields. 502 high-strength LF EMFs-exposed workers were taken as the study subjects. The field intensity indicator and noise analyzer were employed for the examination of the electromagnetic energy intensity and noise value at the working sites. Self-administered questionnaires were adopted. Universal hearing screening by distortion product otoacoustic emission (DPOAE) and pure tone audiometry (PTA) were done. 100 workers who had abnormal POAE were taken as the observation group and 100 workers who had normal DPOAE were taken as the control group. The workers need be confirmed with ABR testing when the pure tone threshold of two consecutive frequencies were above 20 dB HL or DPOAE detection in any frequency did not pass. Multiple factor analysis with logistic regression was performed for the risk factors. The average electric power density in job locations was 21-38 KV/m, which was higher than national standard (< 5 kv/m). Average noise-level in job locations was 52-65 dBHL, which was within the standard (< 85 dB(A). Questionnaire presented that low frequency electric and magnetic fields might increase the incidence of headache, insomnia and tinnitus in the observed group. The incidence of abnormal DPOAE was higher in the subjects of the observed group (P < 0.01). At 676, 933, 3616, 5 130, 7253 Hz, the DPOAE amplitudes of the observed group workers were significantly lower than the control group. Multivariate analysis showed that the risk factors of abnormal DPOAE included exposure of EMF, length of service, daily exposure time, conservatory measures might be protective factors. The changes of DPOAE indicated that the exposure to low frequency electric and magnetic fields had a subtle, discreet and localized impairing effects on outer hair cells. Exposure of low frequency electric and magnetic fields, length of service, daily exposure time might be risk factors, conservatory measures might be protective factors.
- 1 November 2013
- Vol. 27 (22) , 1247-51
[Analysis on outer hair cells hazards from occupational exposure to low frequency electric and magnetic fields and magnetic fields and its related factors].
To explore the function of outer hair cells and its influencing factors in the workers of occupational exposure to low frequency electric and magnetic fields. 502 high-strength LF EMFs-exposed workers were taken as the study subjects. The field intensity indicator and noise analyzer were employed for the examination of the electromagnetic energy intensity and noise value at the working sites. Self-administered questionnaires were adopted. Universal hearing screening by distortion product otoacoustic emission (DPOAE) and pure tone audiometry (PTA) were done. 100 workers who had abnormal POAE were taken as the observation group and 100 workers who had normal DPOAE were taken as the control group. The workers need be confirmed with ABR testing when the pure tone threshold of two consecutive frequencies were above 20 dB HL or DPOAE detection in any frequency did not pass. Multiple factor analysis with logistic regression was performed for the risk factors. The average electric power density in job locations was 21-38 KV/m, which was higher than national standard (< 5 kv/m). Average noise-level in job locations was 52-65 dBHL, which was within the standard (< 85 dB(A). Questionnaire presented that low frequency electric and magnetic fields might increase the incidence of headache, insomnia and tinnitus in the observed group. The incidence of abnormal DPOAE was higher in the subjects of the observed group (P < 0.01). At 676, 933, 3616, 5 130, 7253 Hz, the DPOAE amplitudes of the observed group workers were significantly lower than the control group. Multivariate analysis showed that the risk factors of abnormal DPOAE included exposure of EMF, length of service, daily exposure time, conservatory measures might be protective factors. The changes of DPOAE indicated that the exposure to low frequency electric and magnetic fields had a subtle, discreet and localized impairing effects on outer hair cells. Exposure of low frequency electric and magnetic fields, length of service, daily exposure time might be risk factors, conservatory measures might be protective factors.